We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
+116.77%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
10 Year Est. Return
AUM
$138M
AUM Growth
+$69.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.12B
$96.3M 70%
5,664,548
IVVD icon
2
Invivyd
IVVD
$219M
$22.8M 16.6%
9,248,250
TGTX icon
3
TG Therapeutics
TGTX
$8.4B
$4.82M 3.5%
161,600
ARWR icon
4
Arrowhead Research
ARWR
$10.5B
$4.47M 3.25%
67,400
GUTS icon
5
Fractyl Health
GUTS
$129M
$4.08M 2.97%
1,856,117
PRQR icon
6
ProQR Therapeutics
PRQR
$240M
$2.06M 1.5%
1,019,498
RCKT icon
7
Rocket Pharmaceuticals
RCKT
$376M
$1.35M 0.98%
385,680
SLN
8
Silence Therapeutics
SLN
$496M
$1.13M 0.82%
185,100
CRIS icon
9
Curis
CRIS
$9.02M
$514K 0.37%
26,053

Similar funds

M28 Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, M28 Capital Management held 9 positions worth $138M, up 102% from $68M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 0%. M28 Capital Management opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • M28 Capital Management's ten largest holdings make up 100% of its $138M portfolio in Q4 2025.
  • M28 Capital Management opened 0 new positions and closed 0 in Q4 2025.
  • M28 Capital Management's portfolio value rose 102% quarter-over-quarter to $138M.

Based on M28 Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.